/AVAH
AVAH Stock - Aveanna Healthcare Holdings Inc.
Healthcare|Medical - Care FacilitiesNASDAQ
$9.09+0.11%
+$0.01 (+0.11%) • Dec 19
68
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.79
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).88
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.38
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+18.8%upside
Target: $10.80
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for AVAH
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$9.00 – $9.18
TARGET (TP)$10.80
STOP LOSS$8.36
RISK/REWARD1:2.3
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta2.04
52W High$10.32
52W Low$3.67
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $2.02B | $1.90B | $1.79B | $1.68B | $1.50B |
| Gross Profit | $635.54M | $595.43M | $553.23M | $542.40M | $454.51M |
| Gross Margin | 31.4% | 31.4% | 30.9% | 32.3% | 30.4% |
| Operating Income | $139.79M | $8.07M | $-642,276,000 | $-36,111,000 | $-3,487,000 |
| Net Income | $-10,929,000 | $-134,524,000 | $-662,034,000 | $-117,044,000 | $-57,050,000 |
| Net Margin | -0.5% | -7.1% | -37.0% | -7.0% | -3.8% |
| EPS | $-0.06 | $-0.71 | $-3.57 | $-0.63 | $-0.31 |
Company Overview
Aveanna Healthcare Holdings Inc., a diversified home care platform company, provides private duty nursing (PDN), adult home health and hospice, home-based pediatric therapy, and enteral nutrition services in the United States. Its patient- centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals. The company operates through three segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment offers PDN services, which include in-home skilled nursing services to medically fragile children; nursing services in school settings in which its caregivers accompany patients to school; services to patients in its pediatric day healthcare centers; and employer of record support and personal care services, as well as in-clinic and home-based pediatric therapy services, such as physical, occupational, and speech services. The HHH segment provides home health services, including in-home skilled nursing services; physical, occupational, and speech therapy services; and medical social and aide services, as well as hospice services for patients and their families when a life-limiting illness no longer responds to cure-oriented treatments. The MS segment offers enteral nutrition supplies and other products to adults and children delivered on a periodic or as-needed basis. The company was incorporated in 2016 and is headquartered in Atlanta, Georgia.
Visit WebsiteRating Distribution
Strong Buy
0%
Buy / Outperform
3
23%
Hold / Neutral
7
54%
Sell / Underperform
3
23%
Analyst Consensus🔴 Bearish
3 Bullish10 Neutral/Bearish
Price Targets
$5
Average Target
↓ 44.6% Downside
Now
$1
Low
$5
Average
$11
High
Based on 13 analysts
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| December 8th 2025 | William Blair | Initiation | Outperform | - |
| November 13th 2025 | BMO Capital Markets | Initiation | Outperform | $11 |
| September 18th 2025 | JP Morgan | Upgrade | Neutral | $10 |
| August 19th 2025 | Barclays | Upgrade | Overweight | $9.5 |
| August 19th 2025 | UBS | Upgrade | Neutral | $8 |
| July 21st 2025 | Jefferies | Upgrade | Buy | $6 |
| July 2nd 2025 | Barclays | Initiation | Equal Weight | $5.5 |
| December 13th 2023 | JP Morgan | Downgrade | Underweight | - |
| November 30th 2023 | UBS | Initiation | Sell | $1.5 |
| May 12th 2023 | Raymond James | Downgrade | Market Perform | - |
| January 27th 2023 | Credit Suisse | Downgrade | Underperform | $1← $2 |
| November 21st 2022 | RBC Capital Mkts | Downgrade | Sector Perform | $3← $7 |
| November 17th 2022 | Credit Suisse | Downgrade | Neutral | $2← $5.5 |
| July 22nd 2022 | Jefferies | Downgrade | Hold | $2.5 |
| July 5th 2022 | Truist | Downgrade | Hold | - |
Earnings History & Surprises
AVAHBeat Rate
44%
Last 18 quarters
Avg Surprise
+103.0%
EPS vs Estimate
Beats / Misses
8/9
1 met exactly
Latest EPS
$0.15
Q4 2025
EPS Surprise History
Q1 24
-15.7%
$-0.01vs$-0.01
Q2 24
+40.0%
$-0.03vs$-0.05
Q3 24
+150.0%
$0.01vs$0.00
Q4 24
+254.0%
$0.02vs$0.01
Q1 25
+1178.8%
$0.05vs$0.00
Q2 25
+216.8%
$0.10vs$0.03
Q3 25
+350.0%
$0.18vs$0.04
Q4 25
+87.5%
$0.15vs$0.08
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 6, 2026 | — | — | — | — |
Q1 2026 | Mar 12, 2026 | $0.12 | — | — | — |
Q4 2025 | Nov 6, 2025 | $0.08 | $0.15 | +87.5% | ✓ BEAT |
Q3 2025 | Aug 7, 2025 | $0.04 | $0.18 | +350.0% | ✓ BEAT |
Q2 2025 | May 8, 2025 | $0.03 | $0.10 | +216.8% | ✓ BEAT |
Q1 2025 | Mar 13, 2025 | $0.00 | $0.05 | +1178.8% | ✓ BEAT |
Q4 2024 | Nov 7, 2024 | $0.01 | $0.02 | +254.0% | ✓ BEAT |
Q3 2024 | Aug 8, 2024 | $0.00 | $0.01 | +150.0% | ✓ BEAT |
Q2 2024 | May 9, 2024 | $-0.05 | $-0.03 | +40.0% | ✓ BEAT |
Q1 2024 | Mar 14, 2024 | $-0.01 | $-0.01 | -15.7% | ✗ MISS |
Q4 2023 | Nov 9, 2023 | $-0.03 | $-0.03 | -12.5% | ✗ MISS |
Q3 2023 | Aug 10, 2023 | $-0.01 | $-0.02 | -44.8% | ✗ MISS |
Q2 2023 | May 11, 2023 | $-0.06 | $-0.05 | +16.7% | ✓ BEAT |
Q1 2023 | Mar 16, 2023 | $-0.02 | $-0.03 | -81.1% | ✗ MISS |
Q4 2022 | Nov 9, 2022 | $-0.01 | $-0.03 | -185.7% | ✗ MISS |
Q3 2022 | Aug 10, 2022 | $0.06 | $0.03 | -50.0% | ✗ MISS |
Q2 2022 | May 11, 2022 | $0.06 | $0.04 | -33.3% | ✗ MISS |
Q1 2022 | Mar 28, 2022 | $0.11 | $0.10 | -9.1% | ✗ MISS |
Q4 2021 | Nov 15, 2021 | $0.12 | $0.11 | -8.3% | ✗ MISS |
Q3 2021 | Aug 11, 2021 | $0.10 | $0.10 | 0.0% | = MET |
Latest News
William Blair Initiates Coverage On Aveanna Healthcare Hldgs with Outperform Rating
📈 PositiveBenzinga•Dec 8, 2025, 02:29 PM
BMO Capital Initiates Coverage On Aveanna Healthcare Hldgs with Outperform Rating, Announces Price Target of $11
📈 PositiveBenzinga•Nov 13, 2025, 11:07 AM
UBS Maintains Neutral on Aveanna Healthcare Hldgs, Raises Price Target to $9.5
➖ NeutralBenzinga•Nov 7, 2025, 04:20 PM•Also:
Truist Securities Maintains Hold on Aveanna Healthcare Hldgs, Raises Price Target to $10
➖ NeutralBenzinga•Nov 7, 2025, 03:43 PM
Aveanna Healthcare Holdings shares are trading lower. The company reported Q3 financial results.
📉 NegativeBenzinga•Nov 6, 2025, 01:54 PM
Aveanna Healthcare Hldgs Sees FY2025 Sales Greater Than $2.375B vs $2.328B Est, Updated From Greater Than $2.3B
📈 PositiveBenzinga•Nov 6, 2025, 11:33 AM
Aveanna Healthcare Hldgs Q3 Adj. EPS $0.15 Beats $0.10 Estimate, Sales $621.942M Beat $592.217M Estimate
📈 PositiveBenzinga•Nov 6, 2025, 11:31 AM
Jefferies Maintains Buy on Aveanna Healthcare Hldgs, Raises Price Target to $12.5
📈 PositiveBenzinga•Oct 28, 2025, 06:56 PM•Also:
RBC Capital Maintains Sector Perform on Aveanna Healthcare Hldgs, Raises Price Target to $10
📈 PositiveBenzinga•Oct 24, 2025, 01:59 PM•Also:
Aveanna Healthcare Holdings shares are trading lower after the company announced preliminary Q3 financial results. Also, the company announced a secondary offering of 10 million shares.
📉 NegativeBenzinga•Oct 22, 2025, 01:11 PM
Reported Earlier, Aveanna Healthcare Prices Secondary Offering Of 10M Shares By J.H. Whitney Equity Partners VII At $9 Per Share
➖ NeutralBenzinga•Oct 22, 2025, 07:35 AM
Aveanna Heathcare dips 8%, prices 10M share secondary offering
📉 NegativeSeeking Alpha•Oct 22, 2025, 05:45 AM
Aveanna Healthcare's Selling Stockholders Affiliated With Whitney Equity Partners Launch 10M Common Stock Offering
📉 NegativeBenzinga•Oct 21, 2025, 08:21 PM
Aveanna Healthcare Holdings Announces Preliminary Q3 Financial Results; Sees Revenue Of ~$616M-$624M; Net Income Of ~$11M-$15M; Adjusted EBITDA Of ~$77M-$81M
📈 PositiveBenzinga•Oct 21, 2025, 08:20 PM
UBS Maintains Neutral on Aveanna Healthcare Hldgs, Raises Price Target to $9
➖ NeutralBenzinga•Oct 13, 2025, 02:07 PM
Aveanna Healthcare Closes $1.325B Credit Facility Refinance, Adds $439M In New Loans, Upsizes Revolver To $250M, And Extends Maturities To 2032
📈 PositiveBenzinga•Sep 18, 2025, 11:33 AM
JP Morgan Upgrades Aveanna Healthcare Hldgs to Neutral, Raises Price Target to $10
📈 PositiveBenzinga•Sep 18, 2025, 10:57 AM•Also:
UBS Upgrades Aveanna Healthcare Hldgs to Neutral, Raises Price Target to $8
➖ NeutralBenzinga•Aug 19, 2025, 12:37 PM
Barclays Upgrades Aveanna Healthcare Hldgs to Overweight, Raises Price Target to $9.5
📈 PositiveBenzinga•Aug 19, 2025, 12:35 PM•Also:
Aveanna hits 52-week high as Raymond James upgrades on Q2 beat
📈 PositiveSeeking Alpha•Aug 11, 2025, 07:11 PM
Frequently Asked Questions about AVAH
What is AVAH's current stock price?
Aveanna Healthcare Holdings Inc. (AVAH) is currently trading at $9.09 per share. The stock has moved +0.11% today.
What is the analyst price target for AVAH?
The average analyst price target for AVAH is $10.80, based on 1 analyst.
What sector is Aveanna Healthcare Holdings Inc. in?
Aveanna Healthcare Holdings Inc. operates in the Healthcare sector, specifically within the Medical - Care Facilities industry. The company is traded on the NASDAQ exchange.
What is AVAH's market cap?
Aveanna Healthcare Holdings Inc. has a market capitalization of $1.90 billion, making it a small-cap company.
Does AVAH pay dividends?
No, Aveanna Healthcare Holdings Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorACHC
Acadia Healthcare Company, Inc.
$14.41
Mkt Cap: $1.3B
ADUS
Addus HomeCare Corporation
$112.82
Mkt Cap: $2.1B
ARDT
Ardent Health Partners, LLC
$8.81
Mkt Cap: $1.3B
ASTH
Astrana Health, Inc.
$23.87
Mkt Cap: $1.2B
BKD
Brookdale Senior Living Inc.
$10.79
Mkt Cap: $2.6B
LFST
LifeStance Health Group, Inc.
$7.05
Mkt Cap: $2.7B
LMAT
LeMaitre Vascular, Inc.
$84.96
Mkt Cap: $1.9B
MD
Pediatrix Medical Group, Inc.
$21.91
Mkt Cap: $1.9B
NHC
National HealthCare Corporation
$141.64
Mkt Cap: $2.2B
SEM
Select Medical Holdings Corporation
$15.01
Mkt Cap: $1.9B
Explore stocks similar to AVAH for comparison